M. Povero, L. Pradelli, P. Turco, and R. W. Dal Negro, “Real‑life cost and cost‑effectiveness for tiotropium 18 μg od monotherapy in moderate and severe COPD patients: a 48‑month survey”, FE, vol. 15, no. 2, pp. 39–44, Jun. 2014.